多血小板血漿の欧州市場：世界の産業分析、規模、シェア、成長、動向、予測（2024年～2031年）

当レポートでは、欧州の多血小板血漿市場について調査分析し、市場促進要因、動向、機会、促進要因、課題などの重要な市場力学の評価や、市場構造に関する詳細な見識を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の概要

• 市場の範囲と定義
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
  • 課題
  • 主要動向
• マクロ経済要因
  • 欧州の部門の見通し
  • 欧州のGDP成長の見通し
• COVID-19の影響の分析
• 予測要因 - 関連性と影響

第3章 付加価値考察

• 製品採用分析
• 規制情勢
• バリューチェーン分析
• 主な取引と合併
• PESTLE分析
• ポーターのファイブフォース分析

第4章 価格動向の分析

• 主なハイライト
• 製品の価格に影響を与える主な要因
• 価格分析：製品タイプ別
• 地域の価格と製品の選好

第5章 欧州の多血小板血漿市場の見通し：実績と予測

• 主なハイライト
  • 市場予測
  • 市場と前年比成長
• 市場の分析と予測
  • 市場の実績の分析
  • 現在の市場の分析と予測
• 欧州の多血小板血漿市場の見通し：製品タイプ別
  • イントロダクション/主な調査結果
  • 市場の実績と分析：製品タイプ別
  • 現在の市場と分析と予測：製品タイプ別
• 市場の魅力分析：製品タイプ別
• 欧州の多血小板血漿市場の見通し：由来
  • イントロダクション/主な調査結果
  • 市場の実績の分析：由来別
  • 現在の市場の分析と予測：由来別
• 市場の魅力分析：起源
• 欧州の多血小板血漿市場の見通し：用途
  • イントロダクション/主な調査結果
  • 市場の実績の分析：用途別
  • 現在の市場の分析と予測：用途別
• 市場の魅力分析：用途

第6章 欧州の多血小板血漿市場の見通し：国別

• 主なハイライト
• 市場の実績と分析：国別
• 現在の市場と分析と予測：国別
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • トルコ
  • その他の欧州
• 市場の魅力分析：国

第7章 競合情勢

• 市場シェア分析（2024年）
• 市場構造
  • 競合激化マップ：市場別
  • 競合ダッシュボード
• 企業プロファイル（詳細 - 概要、財務、戦略、近年の動向）
  • Arthrex, Inc.
  • Stryker Corporation
  • Johnson and Johnson Ltd.
  • Zimmer Biomet Holdings Inc.
  • Terumo Corporation
  • Glofinn Oy
  • Medira Ltd.
  • Regen Lab S.A.

第8章 付録

Persistence Market Research has recently released a comprehensive report on the Europe Platelet Rich Plasma (PRP) Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the Europe Platelet Rich Plasma Market from 2024 to 2031.

Key Insights:

• Europe Platelet Rich Plasma Market Size (2024E): US$ 90.9 Mn
• Projected Market Value (2031F):US$ 165.2 Mn
• Europe Market Growth Rate (CAGR 2024 to 2031):8.9%

Europe Platelet Rich Plasma Market - Report Scope:

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine and aesthetic treatments, utilized across medical fields for tissue repair, hair restoration, and skincare applications. PRP is derived from the patient's own blood, processed to concentrate platelets, and then injected into targeted areas to stimulate healing and cellular regeneration. The Europe PRP market addresses a wide range of medical and cosmetic needs across hospitals, clinics, sports medicine facilities, and dermatology centers. Market growth is driven by the increasing popularity of minimally invasive treatments, rising awareness of regenerative therapies, and the expanding adoption of PRP in sports medicine and aesthetics.

Market Growth Drivers:

The Europe PRP market is propelled by several key factors, including the rising demand for aesthetic procedures, especially in anti-aging and skin rejuvenation treatments. The growing incidence of sports-related injuries and the increasing number of elderly patients seeking non-surgical treatments further support market expansion. Advancements in PRP preparation methods and equipment, allowing for faster, more effective results, also contribute to growth. Additionally, the regulatory approval of PRP therapies in various European countries has expanded the scope of PRP applications, from orthopedics and wound care to cosmetic enhancements.

Market Restraints:

Despite promising growth prospects, the PRP market in Europe faces challenges related to the high cost of PRP procedures and limited reimbursement policies. Regulatory restrictions surrounding the classification of PRP as a medical product in certain regions add complexity to market expansion. Inconsistent treatment outcomes due to variability in PRP preparation techniques and the lack of standardization in clinical protocols can also limit adoption. Addressing these regulatory and financial barriers requires collaboration between healthcare providers, regulatory agencies, and manufacturers to ensure safe and accessible PRP treatments across Europe.

Market Opportunities:

The Europe PRP market presents significant growth opportunities driven by emerging technological advancements, demographic trends, and evolving healthcare and wellness models. Integration of PRP with other regenerative treatments, such as stem cell therapies, holds potential for expanded applications in orthopedics and dermatology. Furthermore, the growing demand for PRP in hair restoration therapies across European markets offers additional revenue streams. Strategic partnerships, investments in research and development, and the launch of cost-effective PRP preparation kits are essential to capitalize on these opportunities and secure a leading position in this evolving market landscape.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the PRP market in Europe?
• Which applications and settings are driving PRP adoption across different medical fields?
• How are advancements in PRP technology impacting the competitive landscape of the market?
• Who are the leading companies in the European PRP market, and what strategies are they employing?
• What are the emerging trends and future prospects in the Europe PRP market?

Competitive Intelligence and Business Strategy:

Leading players in the Europe PRP market, including Zimmer Biomet, EmCyte Corporation, Regen Lab SA, and Arthrex Inc., focus on product innovation, regulatory approvals, and strategic collaborations. These companies invest in research to improve PRP formulations and efficiency, catering to various patient needs and clinical applications. Partnerships with medical providers, training programs for healthcare professionals, and patient education initiatives promote market adoption and technology usage. Key companies prioritize user-friendly PRP kits and emphasize compliance with European regulatory standards to maintain market relevance and foster growth in the dynamic PRP market.

Key Companies Profiled:

• Zimmer Biomet
• EmCyte Corporation
• Regen Lab SA
• Arthrex Inc.
• Terumo Corporation
• Eclipse Aesthetics
• Juventix Regenerative Medical
• Stryker Corporation
• Cytomedix
• AdiStem Ltd.

Market Segmentation

By Product Type

• Pure Platelet Rich Plasma (P-PRP)
• Leukocyte-Rich Platelet Rich Plasma (L-PRP)
• Leukocyte-Platelet-Rich Fibrin (L-PRF)
• Pure Platelet Rich Fibrin (P-PRF)

By Origin

• Autologous
• Homologous
• Allogeneic

By Application

• Orthopedic Surgery
• Cosmetic Surgery
• General Surgery
• Neurosurgery

By Country

• Germany
• France
• The United Kingdom
• Italy
• Spain
• Russia
• Turkey
• Rest of Europe

Table of Contents

1. Executive Summary

• 1.1. Europe Platelet Rich Plasma Market Snapshot, 2024-2031
• 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Europe Sectorial Outlook
  • 2.3.2. Europe GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Product Adoption Analysis
• 3.2. Regulatory Landscape
• 3.3. Value Chain Analysis
• 3.4. Key Deals and Mergers
• 3.5. PESTLE Analysis
• 3.6. Porter's Five Force Analysis

4. Price Trend Analysis, 2019-2031

• 4.1. Key Highlights
• 4.2. Key Factors Impacting Product Prices
• 4.3. Pricing Analysis, By Product Type
• 4.4. Regional Prices and Product Preferences

5. Europe Platelet Rich Plasma Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 5.1. Key Highlights
  • 5.1.1. Market Volume (Units) Projections
  • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
  • 5.1.3. Absolute $ Opportunity
• 5.2. Market Size (US$ Mn) Analysis and Forecast
  • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2023
  • 5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2024-2031
• 5.3. Europe Platelet Rich Plasma Market Outlook: Product Type
  • 5.3.1. Introduction / Key Findings
  • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product Type, 2019-2023
  • 5.3.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2024-2031
    • 5.3.3.1. Pure Platelet Rich Plasma (P-PRP)
    • 5.3.3.2. Leukocyte-rich Platelet Rich Plasma (L-PRP)
    • 5.3.3.3. Leukocyte-Platelet-Rich Fibrin (L-PRF)
    • 5.3.3.4. Pure Platelet Rich Fibrin (P-PRF)
    • 5.3.3.5. Others
• 5.4. Market Attractiveness Analysis: Product Type
• 5.5. Europe Platelet Rich Plasma Market Outlook: Origin
  • 5.5.1. Introduction / Key Findings
  • 5.5.2. Historical Market Size (US$ Mn) Analysis, By Origin, 2019-2023
  • 5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Origin, 2024-2031
    • 5.5.3.1. Autologous
    • 5.5.3.2. Homologous
    • 5.5.3.3. Allogeneic
• 5.6. Market Attractiveness Analysis: Origin
• 5.7. Europe Platelet Rich Plasma Market Outlook: Application
  • 5.7.1. Introduction / Key Findings
  • 5.7.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
  • 5.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 5.7.3.1. Orthopedic Surgery
    • 5.7.3.2. Cosmetic Surgery
    • 5.7.3.3. General Surgery
    • 5.7.3.4. Neurosurgery
    • 5.7.3.5. Others
• 5.8. Market Attractiveness Analysis: Application

6. Europe Platelet Rich Plasma Market Outlook: Country

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Country, 2019-2023
• 6.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Country, 2024-2031
  • 6.3.1. Germany
  • 6.3.2. France
  • 6.3.3. U.K.
  • 6.3.4. Italy
  • 6.3.5. Spain
  • 6.3.6. Russia
  • 6.3.7. Turkey
  • 6.3.8. Rest of Europe
• 6.4. Market Attractiveness Analysis: Country

7. Competition Landscape

• 7.1. Market Share Analysis, 2024
• 7.2. Market Structure
  • 7.2.1. Competition Intensity Mapping By Market
  • 7.2.2. Competition Dashboard
• 7.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 7.3.1. Arthrex, Inc.
    • 7.3.1.1. Overview
    • 7.3.1.2. Segments and Product Types
    • 7.3.1.3. Key Financials
    • 7.3.1.4. Market Developments
    • 7.3.1.5. Market Strategy
  • 7.3.2. Stryker Corporation
  • 7.3.3. Johnson and Johnson Ltd.
  • 7.3.4. Zimmer Biomet Holdings Inc.
  • 7.3.5. Terumo Corporation
  • 7.3.6. Glofinn Oy
  • 7.3.7. Medira Ltd.
  • 7.3.8. Regen Lab S.A.

8. Appendix

• 8.1. Research Methodology
• 8.2. Research Assumptions
• 8.3. Acronyms and Abbreviations